Rankings
▼
Calendar
BCYC Q2 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-8.4% YoY
Gross Profit
-$5M
-329.5% margin
Operating Income
-$8M
-524.8% margin
Net Income
-$10M
-671.3% margin
EPS (Diluted)
$-1.40
QoQ Revenue Growth
-76.2%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$905,000
Balance Sheet
Total Assets
$126M
Total Liabilities
$22M
Stockholders' Equity
$105M
Cash & Equivalents
$109M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
-8.4%
Gross Profit
-$5M
-$3M
-54.0%
Operating Income
-$8M
-$5M
-61.1%
Net Income
-$10M
-$5M
-105.2%
← FY 2019
All Quarters
Q3 2019 →